Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial regeneration: present and future trends.

S Etzion1, L H Kedes, R A Kloner

  • 1Neufeld Cardiac Research Institute, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel.

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|January 20, 2004
PubMed
Summary

Regenerating heart muscle after injury is challenging as cardiomyocytes do not proliferate. Promising strategies like gene therapy and cell transplantation show potential for myocardial regeneration in animal models, offering hope for heart attack treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.

International journal of clinical practice·2013
Same author

Emotional stressors trigger cardiovascular events.

International journal of clinical practice·2012
Same author

Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

The endothelial cell in health and disease: its function, dysfunction, measurement and therapy.

International journal of impotence research·2009
Same author

How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.

International journal of impotence research·2009
Same author

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

International journal of impotence research·2009

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Biotechnology

Background:

  • Cardiomyocytes are terminally differentiated cells that cannot proliferate after myocardial injury.
  • Heart failure resulting from myocardial damage necessitates innovative therapeutic strategies.
  • Current treatments for heart failure, such as transplantation, face limitations, especially for elderly patients.

Purpose of the Study:

  • To explore the potential of genetic modulation, cell transplantation, and tissue engineering for myocardial regeneration.
  • To evaluate the efficacy of these approaches in animal models for treating heart failure.
  • To identify challenges hindering the clinical translation of these regenerative strategies.

Main Methods:

  • Investigating genetic modulation techniques to enhance cardiomyocyte function or proliferation.

Related Experiment Videos

  • Assessing the integration and therapeutic effects of transplanted myogenic cells in injured myocardium.
  • Exploring tissue engineering approaches for creating functional cardiac tissue grafts.

    • Main Results:

    • Animal models demonstrate the feasibility of using genetic materials or myogenic cells for myocardial repair.
    • These regenerative strategies show promise as alternatives to heart transplantation, particularly for specific patient groups.
    • Significant challenges remain in translating these experimental findings into efficient clinical therapies.

    Conclusions:

    • Genetic modulation, cell transplantation, and tissue engineering represent promising avenues for myocardial regeneration.
    • While successful in preclinical studies, these approaches require further development to overcome existing hurdles.
    • Efficient therapeutic strategies for heart regeneration are still under development and not yet ready for widespread clinical application.